Ocupress (Carteolol Hydrochloride Ophthalmic) - Summary

OCUPRESS SUMMARY

Ocupress

Ocupress^® (carteolol hydrochloride ophthalmic solution), 1%, is a nonselective beta-adrenoceptor blocking agent for ophthalmic use.

Ocupress (carteolol OPHTHALMIC) is indicated for the following:

Ocupress Ophthalmic Solution, 1%, has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma and intraocular hypertension. It may be used alone or in combination with other intraocular pressure lowering medications.

See all Ocupress indications & dosage >>

OCUPRESS NEWS HIGHLIGHTS

Published Studies Related to Ocupress (Carteolol Ophthalmic)

[Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product] [2007.06]

Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial. [2006.08]

Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension. [2007]

Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride. [2006.01]

more >>